Anna Christine Mccracken, CNM | |
3601 The Vanderbilt Clinic, Nashville, TN 37232-3100 | |
(615) 936-9177 | |
Not Available |
Full Name | Anna Christine Mccracken |
---|---|
Gender | Female |
Speciality | Certified Nurse Midwife (cnm) |
Experience | 3 Years |
Location | 3601 The Vanderbilt Clinic, Nashville, Tennessee |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1386398790 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
367A00000X | Advanced Practice Midwife | 31039 (Tennessee) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Vanderbilt University Medical Center | 5092023416 | 2711 |
News Archive
A new study from Canada, published in the Journal of Psychopharmacology, suggests that many people with PTSD may be getting help with their condition from the use of cannabis. For the first time ever, this research documents how cannabis use is related both to PTSD and to mental health outcomes in the general population.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
There is a surprise benefit to being either an only child, the oldest sibling or even enduring some allergies – you are significantly less likely to develop non-Hodgkin lymphoma (NHL), according to new research from the University of New South Wales (UNSW).
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.
› Verified 1 days ago
Entity Name | Vanderbilt University Medical Center |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1104202761 PECOS PAC ID: 5092023416 Enrollment ID: O20151006000369 |
News Archive
A new study from Canada, published in the Journal of Psychopharmacology, suggests that many people with PTSD may be getting help with their condition from the use of cannabis. For the first time ever, this research documents how cannabis use is related both to PTSD and to mental health outcomes in the general population.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
There is a surprise benefit to being either an only child, the oldest sibling or even enduring some allergies – you are significantly less likely to develop non-Hodgkin lymphoma (NHL), according to new research from the University of New South Wales (UNSW).
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Anna Christine Mccracken, CNM 3841 Green Hills Village Dr Ste 200, Nashville, TN 37215-2691 Ph: () - | Anna Christine Mccracken, CNM 3601 The Vanderbilt Clinic, Nashville, TN 37232-3100 Ph: (615) 936-9177 |
News Archive
A new study from Canada, published in the Journal of Psychopharmacology, suggests that many people with PTSD may be getting help with their condition from the use of cannabis. For the first time ever, this research documents how cannabis use is related both to PTSD and to mental health outcomes in the general population.
European and Turkish doctors and technicians are perfecting a medical support system that can track patients' real-time vital signs, link those to patient medical history, and, crucially, provide the latest clinical guidelines for patient care. Better yet, it can alert doctors when necessary.
There is a surprise benefit to being either an only child, the oldest sibling or even enduring some allergies – you are significantly less likely to develop non-Hodgkin lymphoma (NHL), according to new research from the University of New South Wales (UNSW).
Cardio3 BioSciences, a leading Belgian biotechnology company specialising in cell-based therapies for the treatment of cardiovascular diseases, announced today promising results in a pre-clinical study of its proprietary C-Cath(R) catheter which is under development to administer a range of bio-therapeutics to the heart. C-Cath is designed to take into account organ tissue structure and properties to maximize patients' safety, improve performance and increase user confidence during the injection procedure.
BioMarin Pharmaceutical Inc. today announced its program for BMN-111, a peptide therapeutic for the treatment of achondroplasia. BioMarin plans to file an IND in the fourth quarter of 2011 and to initiate a Phase 1 clinical trial by the first quarter of 2012.
› Verified 1 days ago
Mrs. Lydia Kelly, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 | |
Nicole Mercer, NP-C, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Megan Donohue, CNM Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-936-2000 | |
Letitia C Rainey, APN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 5201 Charlotte Ave, Nashville, TN 37209 Phone: 615-222-1900 Fax: 615-222-1917 | |
Sabyl Elena Farmer, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Sierra Mcgowan, APRN, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-5000 | |
Kameron D Brainard, CNM, APN Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 3601 The Vanderbilt Clinic, Nashville, TN 37232 Phone: 615-322-3000 |